BioXcel Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $256 | $98 | $120 | $168 |
Gross Profit | 150 | 12 | 13 | 154 |
EBITDA | -10,101 | -26,463 | -14,890 | -3,185 |
EBIT | -10,175 | -26,538 | -14,965 | -3,261 |
Net Income | -12,545 | -30,911 | -19,187 | -7,254 |
Net Change In Cash | 256 | 98 | 120 | 168 |
Free Cash Flow | -14,210 | -18,787 | -12,575 | -12,043 |
Cash | 28,415 | 37,320 | 17,435 | 31,013 |
Basic Shares | 12,208 | 14,196 | 7,843 | 4,834 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $642 | $2,266 | $1,380 | $375 |
Gross Profit | 178 | 123 | 120 | 355 |
EBITDA | -49,405 | -44,161 | -165,421 | -157,217 |
EBIT | -49,705 | -44,470 | -165,739 | -157,544 |
Net Income | -69,897 | -59,599 | -179,053 | -165,757 |
Net Change In Cash | 642 | 2,266 | 1,380 | 375 |
Cost of Revenue | -39,243 | |||
Free Cash Flow | -57,615 | -72,027 | -155,026 | -135,480 |
Cash | 28,415 | 29,854 | 65,221 | 193,725 |
Basic Shares | 12,208 | 2,535 | 1,820 | 1,750 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.02 |
2025-09-30 | -$2.18 |
2025-06-30 | -$2.45 |
2025-03-31 | -$1.50 |
